WEBVTT

00:00:00.166 --> 00:00:01.292
Hi, I'm Georgie Frost.

00:00:01.292 --> 00:00:05.171
I'm here on the ground at the JP
Morgan Healthcare Conference in

00:00:05.171 --> 00:00:08.717
San Francisco, talking to BCG
experts about the innovations

00:00:08.717 --> 00:00:11.886
and trends that they're
most excited about for 2025.

00:00:11.886 --> 00:00:14.556
I think I'm most excited to see the continued

00:00:14.556 --> 00:00:16.725
evolution of direct-to-patient therapies.

00:00:16.725 --> 00:00:19.060
The development of new platforms

00:00:19.060 --> 00:00:21.146
focused on getting therapies
into the hands of patients that

00:00:21.146 --> 00:00:24.190
might not necessarily have a tremendous
amount of access to

00:00:24.190 --> 00:00:25.025
those therapies.

00:00:25.066 --> 00:00:28.153
We see new platform
technologies coming to life,

00:00:28.153 --> 00:00:31.114
RLT, the big thing on the oncology side.

00:00:31.114 --> 00:00:32.866
I'm excited about personalization.

00:00:32.866 --> 00:00:35.785
Next generation sequencing
and understanding your

00:00:35.785 --> 00:00:36.870
genome or the

00:00:36.870 --> 00:00:38.038
DNA of your cancer.

00:00:38.121 --> 00:00:40.999
Less innovations on the
admin cost side. Less about

00:00:40.999 --> 00:00:43.126
how we can really get
utilization management to

00:00:43.126 --> 00:00:43.626
where it needs to be.

00:00:43.626 --> 00:00:45.170
Much more on the
medical cost side.

00:00:45.295 --> 00:00:48.381
There are finally therapies
that work for obesity.

00:00:48.423 --> 00:00:51.426
These drugs change
people's lives and change

00:00:51.426 --> 00:00:54.512
the health of billions of people around
the world that can benefit from a

00:00:54.512 --> 00:00:55.680
prevention perspective.

00:00:55.680 --> 00:00:58.516
We're crossing the chasm on the
consumer side and is

00:00:58.516 --> 00:01:02.103
a lot of more willingness in
terms of adoption, usage.

00:01:02.103 --> 00:01:06.232
And that's really what's needed to
make sure we get to scalability.

00:01:06.524 --> 00:01:08.777
A lot of the applications were
much more internally

00:01:08.777 --> 00:01:11.446
focused around productivity,
but we're now seeing AI and

00:01:11.446 --> 00:01:15.075
GenAI start to embed themselves
into customer-facing products,

00:01:15.075 --> 00:01:18.453
and I think that holds tremendous
promise for the industry as a whole.